Novel approaches to models of Alzheimer’s disease pathology for drug screening and development

By Shaughnessy Laura   Chamblin Beth   McMahon Lori   Nair Ayyappan   Thomas Mary   Wakefield John   Koentgen Frank   Ramabhadran Ram  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 23-32

Humana Press, Inc

Access to resources Recommend Favorite

A New Regulatory Road-Map for Alzheimer’s Disease Drug Development

By  

Current Alzheimer Research, Vol. 11, Iss. 3, 2014-03 ,pp. : 215-220

Bentham Science Publishers

Access to resources Recommend Favorite

Drug discovery for Alzheimer’s disease: The end of the beginning

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 1-8

Humana Press, Inc

Access to resources Recommend Favorite

Tau as a Drug Target in Alzheimer’s Disease

By Gozes Illana  

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 337-338

Humana Press, Inc

Access to resources Recommend Favorite

Impaired Renal Function and Biomarkers of Vascular Disease in Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 11, Iss. 3, 2014-03 ,pp. : 253-258

Bentham Science Publishers

Access to resources Recommend Favorite